BG107793A - Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа' - Google Patents

Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа' Download PDF

Info

Publication number
BG107793A
BG107793A BG107793A BG10779303A BG107793A BG 107793 A BG107793 A BG 107793A BG 107793 A BG107793 A BG 107793A BG 10779303 A BG10779303 A BG 10779303A BG 107793 A BG107793 A BG 107793A
Authority
BG
Bulgaria
Prior art keywords
propyl
piperidine
methoxyquinolin
carboxylic acid
hydroxy
Prior art date
Application number
BG107793A
Other languages
Bulgarian (bg)
English (en)
Inventor
Eric Bacque
Jean-Christophe Carry
Youssef El-Ahmad
Michel Evers
Philippe Hubert
Jean-Luc Malleron
Serge Mignani
Guy Pantel
Michel Tabart
Fabrice Viviani
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG107793A publication Critical patent/BG107793A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG107793A 2000-11-15 2003-05-09 Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа' BG107793A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014738A FR2816618B1 (fr) 2000-11-15 2000-11-15 Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2001/003559 WO2002040474A2 (fr) 2000-11-15 2001-11-14 Derives heterocyclylalcoyl piperidine et leur application comme antimicrobiens

Publications (1)

Publication Number Publication Date
BG107793A true BG107793A (bg) 2004-08-31

Family

ID=8856503

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107793A BG107793A (bg) 2000-11-15 2003-05-09 Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа'

Country Status (28)

Country Link
EP (2) EP1695964A1 (cs)
JP (1) JP2004514661A (cs)
KR (1) KR100849608B1 (cs)
CN (1) CN1483031A (cs)
AR (1) AR034006A1 (cs)
AT (1) ATE337311T1 (cs)
AU (2) AU1836502A (cs)
BG (1) BG107793A (cs)
BR (1) BR0115312A (cs)
CA (1) CA2429311A1 (cs)
CZ (1) CZ20031316A3 (cs)
DE (1) DE60122567T2 (cs)
DK (1) DK1337529T3 (cs)
EA (1) EA200300568A1 (cs)
EE (1) EE200300207A (cs)
ES (1) ES2271119T3 (cs)
FR (1) FR2816618B1 (cs)
HR (1) HRP20030379A2 (cs)
HU (1) HUP0303758A3 (cs)
IL (1) IL155841A0 (cs)
NO (2) NO20032187L (cs)
PL (1) PL363004A1 (cs)
PT (1) PT1337529E (cs)
SK (1) SK5822003A3 (cs)
TN (1) TNSN01160A1 (cs)
WO (1) WO2002040474A2 (cs)
YU (1) YU46803A (cs)
ZA (1) ZA200303794B (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030019621A (ko) 2000-07-26 2003-03-06 스미스클라인비이참피이엘시이 항균 활성을 갖는 아미노피페리딘 퀴놀린 및 그의아자이소스테릭 유사체
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
WO2003064431A2 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200406410A (en) 2002-01-29 2004-05-01 Glaxo Group Ltd Compounds
AR040335A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
AU2003303956A1 (en) 2002-11-05 2004-11-23 Smithkline Beecham Corporation Antibacterial agents
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
DE60324179D1 (de) 2002-12-04 2008-11-27 Glaxo Group Ltd Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2862301B1 (fr) * 2003-11-17 2007-12-21 Aventis Pharma Sa Nouveau procede de preparation de quinoleines 3-fluorees
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
JP2008528588A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
US7648980B2 (en) 2005-01-25 2010-01-19 Glaxo Group Limited Antibacterial agents
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
WO2006094034A1 (en) 2005-03-01 2006-09-08 Wyeth Cinnoline compounds and their use as liver x receptor modilators
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
CA2635126A1 (en) 2006-01-26 2007-08-02 Actelion Pharmaceuticals Ltd Tetrahydropyrane antibiotics
US7709483B2 (en) 2006-04-06 2010-05-04 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
CN101711243B (zh) 2007-06-15 2013-01-09 埃科特莱茵药品有限公司 3-氨基-6-(1-氨基-乙基)-四氢吡喃衍生物
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
EP2352734A1 (en) 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
ES2561631T3 (es) 2009-01-15 2016-02-29 Glaxo Group Limited Compuestos de naftiridin-2(1H)-ona útiles como agentes antibacterianos
US9273001B2 (en) * 2012-08-15 2016-03-01 Glaxo Group Limited Chemical process
CN106659717B (zh) 2014-08-22 2019-09-06 葛兰素史密斯克莱知识产权发展有限公司 用于治疗淋病奈瑟球菌感染的三环含氮化合物
WO2016138988A1 (en) * 2015-03-02 2016-09-09 University Of Copenhagen Piperazine inhibitors of bacterial gyrase and topoisomerase iv
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908031A (nl) 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
JPH0239546A (ja) 1988-07-29 1990-02-08 Origin Electric Co Ltd 混成集積回路の製造方法
NZ232091A (en) 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
ES2201674T3 (es) * 1998-01-26 2004-03-16 Smithkline Beecham Plc Derivados de quinolina con propiedades antibacterianas.
EP1144404A1 (en) * 1999-01-20 2001-10-17 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO20072142L (no) 2007-04-25
ZA200303794B (en) 2004-06-29
KR20030060934A (ko) 2003-07-16
EP1337529B1 (fr) 2006-08-23
TNSN01160A1 (fr) 2005-11-10
EE200300207A (et) 2003-08-15
EA200300568A1 (ru) 2003-12-25
WO2002040474A2 (fr) 2002-05-23
ES2271119T3 (es) 2007-04-16
CA2429311A1 (en) 2002-05-23
EP1337529A2 (fr) 2003-08-27
IL155841A0 (en) 2003-12-23
JP2004514661A (ja) 2004-05-20
PT1337529E (pt) 2006-12-29
HUP0303758A2 (hu) 2004-03-01
DE60122567T2 (de) 2007-08-23
DE60122567D1 (de) 2006-10-05
NO20032187D0 (no) 2003-05-14
NO20032187L (no) 2003-06-26
FR2816618A1 (fr) 2002-05-17
SK5822003A3 (en) 2004-06-08
AU1836502A (en) 2002-05-27
DK1337529T3 (da) 2006-12-18
FR2816618B1 (fr) 2002-12-27
CN1483031A (zh) 2004-03-17
AR034006A1 (es) 2004-01-21
BR0115312A (pt) 2003-09-23
CZ20031316A3 (cs) 2003-10-15
KR100849608B1 (ko) 2008-07-31
ATE337311T1 (de) 2006-09-15
YU46803A (sh) 2006-05-25
HUP0303758A3 (en) 2009-08-28
AU2002218365B2 (en) 2007-07-05
HRP20030379A2 (en) 2005-04-30
EP1695964A1 (fr) 2006-08-30
WO2002040474A3 (fr) 2002-10-31
PL363004A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
BG107793A (bg) Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа'
US6603005B2 (en) Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
US6602884B2 (en) Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
JP4262481B2 (ja) キノリルプロピルピペリジン誘導体、その製造およびそれを含む組成物
US6403610B1 (en) Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
CN100415736C (zh) 喹啉基丙基哌啶衍生物以及其作为抗微生物剂的应用
US7232834B2 (en) Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
CZ2002940A3 (cs) Chinolylpropylpiperidinové deriváty, jejich příprava a jejich pouľití
TWI444380B (zh) 7-胺基亞烷基-雜環喹諾酮及啶酮
KR20120011093A (ko) 치환된 헤테로사이클릭 유도체 및 조성물 및 항균제로서의 이의 약학적 용도
AU658905B2 (en) Methanoanthracenes having antidopaminergic activity
CA2520764A1 (en) 4-substituted quinolein derivatives with antimicrobial activity
CN101023076A (zh) 4-取代的喹啉衍生物,其制备的方法和中间体,以及含有它们的药物组合物
US20040224946A1 (en) 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
CZ20004587A3 (en) Tetrahydroquinoline derivatives
US6806277B2 (en) Quinolylpropylpiperidine derivatives, preparation process and intermediates, and compositions including them